Annual Cash & Cash Equivalents
$216.68 M
-$62.72 M-22.45%
December 31, 2023
Summary
- As of February 24, 2025, HLVX annual cash & cash equivalents is $216.68 million, with the most recent change of -$62.72 million (-22.45%) on December 31, 2023.
- During the last 3 years, HLVX annual cash & cash equivalents has risen by +$216.22 million (+47313.13%).
- HLVX annual cash & cash equivalents is now -22.45% below its all-time high of $279.40 million, reached on December 31, 2022.
Performance
HLVX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$103.76 M
-$4.68 M-4.32%
September 30, 2024
Summary
- As of February 24, 2025, HLVX quarterly cash and cash equivalents is $103.76 million, with the most recent change of -$4.68 million (-4.32%) on September 30, 2024.
- Over the past year, HLVX quarterly cash and cash equivalents has stayed the same.
- HLVX quarterly cash and cash equivalents is now -67.02% below its all-time high of $314.61 million, reached on June 30, 2022.
Performance
HLVX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
HLVX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.4% | 0.0% |
| 3 y3 years | +10000.0% | 0.0% |
| 5 y5 years | +10000.0% | 0.0% |
HLVX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.4% | +74.0% | -67.0% | at low |
| 5 y | 5-year | -22.4% | >+9999.0% | -67.0% | at low |
| alltime | all time | -22.4% | >+9999.0% | -67.0% | at low |
HilleVax Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $103.76 M(-4.3%) |
| Jun 2024 | - | $108.44 M(-23.1%) |
| Mar 2024 | - | $141.08 M(-34.9%) |
| Dec 2023 | $216.68 M(-22.4%) | $216.68 M(+3.9%) |
| Sep 2023 | - | $208.50 M(+31.7%) |
| Jun 2023 | - | $158.38 M(-39.2%) |
| Mar 2023 | - | $260.54 M(-6.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $279.40 M(+124.3%) | $279.40 M(-4.3%) |
| Sep 2022 | - | $292.06 M(-7.2%) |
| Jun 2022 | - | $314.61 M(+182.8%) |
| Mar 2022 | - | $111.25 M(-10.7%) |
| Dec 2021 | $124.57 M(>+9900.0%) | - |
| Dec 2021 | - | $124.57 M |
| Dec 2020 | $457.00 K | - |
FAQ
- What is HilleVax annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for HilleVax?
- What is HilleVax annual cash & cash equivalents year-on-year change?
- What is HilleVax quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for HilleVax?
- What is HilleVax quarterly cash and cash equivalents year-on-year change?
What is HilleVax annual cash & cash equivalents?
The current annual cash & cash equivalents of HLVX is $216.68 M
What is the all time high annual cash & cash equivalents for HilleVax?
HilleVax all-time high annual cash & cash equivalents is $279.40 M
What is HilleVax annual cash & cash equivalents year-on-year change?
Over the past year, HLVX annual cash & cash equivalents has changed by -$62.72 M (-22.45%)
What is HilleVax quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of HLVX is $103.76 M
What is the all time high quarterly cash and cash equivalents for HilleVax?
HilleVax all-time high quarterly cash and cash equivalents is $314.61 M
What is HilleVax quarterly cash and cash equivalents year-on-year change?
Over the past year, HLVX quarterly cash and cash equivalents has changed by $0.00 (0.00%)